Literature DB >> 22479231

New approaches to treat cancer - what they can and cannot do.

Nalân Utku1.   

Abstract

Delivering drugs directly to tumors and overcoming drug resistance are two hurdles that face cancer researchers. Here's a look at where cancer treatment stands.

Entities:  

Year:  2011        PMID： 22479231      PMCID： PMC3278133     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  8 in total

Review 1.  Regulatory T cells, tumour immunity and immunotherapy.

Authors:  Weiping Zou
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

Review 2.  Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

Authors:  Licia Rivoltini; Paola Canese; Veronica Huber; Manuela Iero; Lorenzo Pilla; Roberta Valenti; Stefano Fais; Francesco Lozupone; Chiara Casati; Chiara Castelli; Giorgio Parmiani
Journal:  Expert Opin Biol Ther       Date:  2005-04       Impact factor: 4.388

3.  Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways.

Authors:  Siyuan Zhang; Wen-Chien Huang; Ping Li; Hua Guo; Say-Bee Poh; Samuel W Brady; Yan Xiong; Ling-Ming Tseng; Shau-Hsuan Li; Zhaoxi Ding; Aysegul A Sahin; Francisco J Esteva; Gabriel N Hortobagyi; Dihua Yu
Journal:  Nat Med       Date:  2011-03-13       Impact factor: 53.440

4.  Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody.

Authors:  Tamer A ElBayoumi; Vladimir P Torchilin
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

5.  Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

Authors:  Zeruesenay Desta; Bryan A Ward; Nadia V Soukhova; David A Flockhart
Journal:  J Pharmacol Exp Ther       Date:  2004-05-24       Impact factor: 4.030

6.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

7.  Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles.

Authors:  Jun Wang; Baoan Chen; Jian Chen; Xiaohui Cai; Guohua Xia; Ran Liu; Pingsheng Chen; Yu Zhang; Xuemei Wang
Journal:  Int J Nanomedicine       Date:  2011-01-24

8.  Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds.

Authors:  Caterina Cinti; Monia Taranta; Ilaria Naldi; Settimio Grimaldi
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240
  8 in total
  3 in total

Review 1.  Human papillomavirus infection, cervical cancer and the less explored role of trace elements.

Authors:  Anne Boyina Sravani; Vivek Ghate; Shaila Lewis
Journal:  Biol Trace Elem Res       Date:  2022-04-25       Impact factor: 3.738

Review 2.  Production of recombinant immunotherapeutics for anticancer treatment: the role of bioengineering.

Authors:  Maria-Cristina S Pranchevicius; Thiessa R Vieira
Journal:  Bioengineered       Date:  2013-04-22       Impact factor: 3.269

3.  Effective Penetration of a Liposomal Formulation of Bleomycin through Ex-Vivo Skin Explants from Two Different Species.

Authors:  Giulia Ferrari; Lisa Y Pang; Fabio De Moliner; Marc Vendrell; Richard J M Reardon; Andrew J Higgins; Sunil Chopra; David J Argyle
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.